Cancer in light of experimental evolution

scientific article (publication date: 11 September 2012)

Cancer in light of experimental evolution is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CUB.2012.06.065
P3181OpenCitations bibliographic resource ID2868386
P932PMC publication ID3457634
P698PubMed publication ID22975007
P5875ResearchGate publication ID230848421

P50authorLauren M.F. MerloQ30530341
Philip GerrishQ42842789
Kathleen SprouffskeQ88494847
P2093author name stringCarlo C Maley
Paul D Sniegowski
P2860cites workThe population genetics of dN/dSQ21145026
Animal cell differentiation patterns suppress somatic evolutionQ21145656
Genetic predisposition to cancer — insights from population geneticsQ22122022
Microbial genetics: Evolution experiments with microorganisms: the dynamics and genetic bases of adaptationQ22122024
Cancer as an evolutionary and ecological processQ22122026
Hallmarks of Cancer: The Next GenerationQ22252312
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisQ24602426
A comprehensive catalogue of somatic mutations from a human cancer genomeQ24628532
Complex landscapes of somatic rearrangement in human breast cancer genomesQ24631412
Efficient tumour formation by single human melanoma cellsQ24648938
The basics of epithelial-mesenchymal transitionQ24652992
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingQ24653015
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaQ27851726
Epithelial-mesenchymal transitions in tumour progressionQ27860487
A genetic model for colorectal tumorigenesisQ27860582
A human colon cancer cell capable of initiating tumour growth in immunodeficient miceQ27860831
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingQ27860948
Lethal Mutagenesis: Targeting the Mutator Phenotype in CancerQ35669158
Problems of somatic mutation and cancerQ35677655
Complete genetic linkage can subvert natural selectionQ35748721
Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolutionQ35811223
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infectionQ35818681
Clonal architecture of secondary acute myeloid leukemiaQ35872658
Clonal interference in large populationsQ36156834
Virus dynamics and drug therapyQ36244920
Comparative lesion sequencing provides insights into tumor evolutionQ36670136
Fitness consequences of a regulatory polymorphism in a seasonal environmentQ36689750
Chromosome fragility: molecular mechanisms and cellular consequencesQ36849639
Optimizing drug exposure to minimize selection of antibiotic resistanceQ36903693
Clonal interference, multiple mutations and adaptation in large asexual populationsQ37011413
Oncogene addictionQ37152445
The fixation probability of rare mutators in finite asexual populations.Q37152739
Self-generated diversity produces "insurance effects" in biofilm communitiesQ37621081
Population biological principles of drug-resistance evolution in infectious diseasesQ37849394
Exploring the genomes of cancer cells: progress and promiseQ37857590
Genome-wide approaches to the study of adaptive gene expression evolution: systematic studies of evolutionary adaptations involving gene expression will allow many fundamental questions in evolutionary biology to be addressedQ37871502
Selection and neutrality in lactose operons of Escherichia coliQ38343258
The balance between mutators and nonmutators in asexual populationsQ38517985
Tests of parallel molecular evolution in a long-term experiment with Escherichia coliQ34694847
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencingQ34812680
Deletion at fragile sites is a common and early event in Barrett's esophagus.Q35002032
Accurate reconstruction of the temporal order of mutations in neoplastic progressionQ35091312
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapyQ35092451
Production of resistant HIV mutants during antiretroviral therapyQ35165357
Distinguishing driver and passenger mutations in an evolutionary history categorized by interferenceQ35542057
Immunoglobulin synthesis and total body tumor cell number in IgG multiple myelomaQ35577877
Proliferation of mutators in A cell populationQ35618973
Emergent neutrality in adaptive asexual evolutionQ35620493
Bacterial biofilms: a common cause of persistent infectionsQ27861033
A cell initiating human acute myeloid leukaemia after transplantation into SCID miceQ28131777
Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populationsQ28245607
Selforganization of matter and the evolution of biological macromoleculesQ28248277
Asymmetric and symmetric stem-cell divisions in development and cancerQ28249478
Cancer stem cells: mirage or reality?Q28257690
The clonal evolution of tumor cell populationsQ28271546
Cancer genes and the pathways they controlQ28275089
The origin of mutantsQ28288915
Molecular definition of breast tumor heterogeneityQ28292256
Adaptive protein evolution at the Adh locus in DrosophilaQ28302478
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategiesQ28471733
Pervasive Cryptic Epistasis in Molecular EvolutionQ28475868
Tumour evolution inferred by single-cell sequencingQ28646966
Real time forecasting of near-future evolutionQ28728760
Peto's Paradox: evolution's prescription for cancer preventionQ28741797
Lethal mutagenesis of bacteriaQ28756839
The Evolution of Mutation Rate in Finite Asexual PopulationsQ29301497
Clonal evolution in cancerQ29547696
Patterns of somatic mutation in human cancer genomesQ29547841
Mesenchymal stem cells within tumour stroma promote breast cancer metastasisQ29614303
Detection of mutations in EGFR in circulating lung-cancer cellsQ29615033
Darwinian evolution can follow only very few mutational paths to fitter proteinsQ29616042
The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycleQ29616074
THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCEQ29616118
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseQ29616468
The patterns and dynamics of genomic instability in metastatic pancreatic cancerQ29618121
The clonal and mutational evolution spectrum of primary triple-negative breast cancersQ29619914
Local dispersal promotes biodiversity in a real-life game of rock-paper-scissorsQ31096211
(A)symmetric stem cell replication and cancerQ33279153
The repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited environments in yeastQ33392677
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotypeQ33604942
The role of genetic diversity in cancerQ33604953
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Q33638070
Rate, molecular spectrum, and consequences of human mutationQ33667179
Periodic selection in Escherichia coliQ33711273
Beneficial mutations and the dynamics of adaptation in asexual populations.Q33856627
The increasing complexity of the cancer stem cell paradigmQ33862363
Long-Term Experimental Evolution in Escherichia coli. VIII. Dynamics of a Balanced PolymorphismQ33888665
Drug resistance in cancer: principles of emergence and preventionQ33892278
The evolution of mutation rates: separating causes from consequencesQ33925698
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pyloriQ33952076
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coliQ33963371
Evolutionary consequences of mutation and selection within an individualQ33966095
Exceptional convergent evolution in a virus.Q33971443
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.Q34035601
Ribavirin's antiviral mechanism of action: lethal mutagenesis?Q34119894
Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzymeQ34189506
Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment.Q34202519
Cooperation and conflict in the evolution of multicellularityQ34216636
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumorQ34258285
Accumulation of driver and passenger mutations during tumor progressionQ34276850
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.Q34307548
Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagusQ34321602
Multiple mutations and cancerQ34327554
The speed of evolution and maintenance of variation in asexual populationsQ34330675
The mutation rate and cancerQ34410886
Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiaeQ34415662
Evolution of high mutation rates in experimental populations of E. coliQ34429727
Perspective: Sign epistasis and genetic constraint on evolutionary trajectoriesQ34437784
The solitary wave of asexual evolutionQ34470274
Genetic clonal diversity predicts progression to esophageal adenocarcinomaQ34505745
Mutation and epigenetic molecular clocks in cancerQ34520423
Adaptation in sexuals vs. asexuals: clonal interference and the Fisher-Muller modelQ34589967
Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteriaQ34607018
Enzyme kinetics, substitutable resources and competition: from biochemistry to frequency-dependent selection in lac.Q34615999
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations.Q34616140
The speed of adaptation in large asexual populationsQ34645731
Looking for Darwin in all the wrong places: the misguided quest for positive selection at the nucleotide sequence levelQ34648294
Interfering waves of adaptation promote spatial mixing.Q39028906
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasmQ39386631
Is there any genetic instability in human cancer?Q39683908
Signatures of mutation and selection in the cancer genomeQ39737975
Diminishing returns epistasis among beneficial mutations decelerates adaptationQ39954065
The mutational meltdown in asexual populationsQ41067565
MUTATION LOAD AND THE SURVIVAL OF SMALL POPULATIONS.Q41176863
The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptationQ41853709
Epistasis and the adaptability of an RNA virusQ41907301
Enrichment and elimination of mutY mutators in Escherichia coli populationsQ42031695
Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motorQ42033067
Spatial structure increases the waiting time for cancer.Q42202619
Negative epistasis between beneficial mutations in an evolving bacterial populationQ44010374
The molecular diversity of adaptive convergence.Q46185374
The McDonald-Kreitman test and slightly deleterious mutationsQ50064983
Evolutionary biology of cancer.Q51727179
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.Q51890946
An error catastrophe in cancer?Q52000115
The rhythm of microbial adaptation.Q52054921
Social strife in the microbial world.Q52102611
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.Q53360408
Stochastic elimination of cancer cells.Q53374855
The fate of competing beneficial mutations in an asexual population.Q54262235
Role of mutator alleles in adaptive evolution.Q54564129
Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.Q54587349
Lineage selection and the evolution of multistage carcinogenesis.Q55032938
Adaptive radiation in a heterogeneous environmentQ56038387
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coliQ58870925
Relative fitness can decrease in evolving asexual populations of S. cerevisiaeQ59051577
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populationsQ59092867
THE ADAPTATION RATE OF ASEXUALS: DELETERIOUS MUTATIONS, CLONAL INTERFERENCE AND POPULATION BOTTLENECKSQ60167619
ENVIRONMENTAL HETEROGENEITY ENHANCES CLONAL INTERFERENCEQ60167621
The accumulation of deleterious genes in a population--Muller's RatchetQ67444775
The population genetics of multistage carcinogenesisQ73552224
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemiaQ83830344
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironmentsQ84975610
P433issue17
P407language of work or nameEnglishQ1860
P921main subjectexperimental evolutionQ3592884
P304page(s)R762-71
P577publication date2012-09-01
P1433published inCurrent BiologyQ1144851
P1476titleCancer in light of experimental evolution
P478volume22

Reverse relations

cites work (P2860)
Q35729697A Genetic Incompatibility Accelerates Adaptation in Yeast
Q99578991Application of simultaneous selective pressures slows adaptation
Q38254752Beyond genome sequencing: lineage tracking with barcodes to study the dynamics of evolution, infection, and cancer.
Q28601078Biochemistry and physiology within the framework of the extended synthesis of evolutionary biology
Q26767415Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
Q47313036Cancer Progression Models and Fitness Landscapes: a Many-to-Many Relationship
Q34321565Cancer heterogeneity: implications for targeted therapeutics
Q92963637Clonal evolution and genome stability in a 2500-year-old fungal individual
Q38594523Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse.
Q59125278Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer
Q64078921DNA Damage Stress: Cui Prodest?
Q42206019Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites
Q35777228Evolutionary perspective of cancer: myth, metaphors, and reality
Q57174769Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution
Q92578371Fine-grained simulations of the microenvironment of vascularized tumours
Q37696306First principles of Hamiltonian medicine.
Q47294854Genetic drift and selection in many-allele range expansions
Q89884665Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models
Q28651650Genome dynamics during experimental evolution
Q64963172Genomic clustering of fitness-affecting mutations favors the evolution of chromosomal instability.
Q38724178Host manipulation by cancer cells: Expectations, facts, and therapeutic implications
Q38683761Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization
Q38165448Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
Q36120373Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach
Q30825161Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward Metastasis
Q26766238Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors
Q39047616Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies
Q49541273Modeling the Subclonal Evolution of Cancer Cell Populations
Q38762495Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang
Q28088605Molecular heterogeneity in glioblastoma: potential clinical implications
Q36264128Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing
Q59356259Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma
Q34358875Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations
Q35061276Population dynamics of metastable growth-rate phenotypes
Q26801291Protecting the normal in order to better kill the cancer
Q47115915Resource competition promotes tumour expansion in experimentally evolved cancer.
Q42416137Spatial Moran models, II: cancer initiation in spatially structured tissue
Q94461588Synthetic hybrids of six yeast species
Q28391909Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"
Q33763823The effect of population bottlenecks on mutation rate evolution in asexual populations
Q35573684The reverse evolution from multicellularity to unicellularity during carcinogenesis
Q41918920The shock of being united and symphiliosis. Another lesson from plants?
Q26866803Tumour heterogeneity and the evolution of polyclonal drug resistance
Q55379165Turning natural adaptations to oncogenic factors into an ally in the war against cancer.
Q34387997Whole genome, whole population sequencing reveals that loss of signaling networks is the major adaptive strategy in a constant environment

Search more.